• 1
    Dumoutier, L., Louahed, J. and Renauld, J. C., Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 2000. 164: 18141819.
  • 2
    Xie, M. H., Aggarwal, S., Ho, W. H., Foster, J., Zhang, Z., Stinson, J., Wood, W. I. et al., Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2–4 and IL-22R. J. Biol. Chem. 2000. 275: 3133531339.
  • 3
    Donnelly, R. P., Sheikh, F., Kotenko, S. V. and Dickensheets, H., The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 2004. 76: 314321.
  • 4
    Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y. and Fisher, P. B., Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004. 22: 929979.
  • 5
    Volk, H., Asadullah, K., Gallagher, G., Sabat, R. and Grutz, G., IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol. 2001. 22: 414417.
  • 6
    Dumoutier, L., Van Roost, E., Ameye, G., Michaux, L. and Renauld, J. C., IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 2000. 1: 488494.
  • 7
    Wolk, K., Kunz, S., Asadullah, K. and Sabat, R., Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 2002. 168: 53975402.
  • 8
    Dumoutier, L., Van Roost, E., Colau, D. and Renauld, J. C., Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 2000. 97: 1014410149.
  • 9
    Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P. and Pestka, S., Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 2001. 276: 27252732.
  • 10
    Wolk, K., Witte, E., Reineke, U., Witte, K., Friedrich, M., Sterry, W., Asadullah, K. et al., Is there an interaction between interleukin-10 and interleukin-22? Genes Immun. 2005. 6: 818.
  • 11
    Lejeune, D., Dumoutier, L., Constantinescu, S., Kruijer, W., Schuringa, J. J. and Renauld, J. C., Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 2002. 277: 3367633682.
  • 12
    Dumoutier, L., Lejeune, D., Colau, D. and Renauld, J. C., Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol. 2001. 166: 70907095.
  • 13
    Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P. and Pestka, S., Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 2001. 166: 70967103.
  • 14
    Xu, W., Presnell, S. R., Parrish-Novak, J., Kindsvogel, W., Jaspers, S., Chen, Z., Dillon, S. R. et al., A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acad. Sci. USA 2001. 98: 95119516.
  • 15
    Gruenberg, B. H., Schoenemeyer, A., Weiss, B., Toschi, L., Kunz, S., Wolk, K., Asadullah, K. and Sabat, R., A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun. 2001. 2: 329334.
  • 16
    Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K. and Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 2004. 21: 241254.
  • 17
    Aggarwal, S., Xie, M. H., Maruoka, M., Foster, J. and Gurney, A. L., Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 2001. 21: 10471053.
  • 18
    Radaeva, S., Sun, R., Pan, H. N., Hong, F. and Gao, B., Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004. 39: 13321342.
  • 19
    Whittington, H. A., Armstrong, L., Uppington, K. M. and Millar, A. B., Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell. Mol. Biol. 2004. 31: 220226.
  • 20
    Nagalakshmi, M. L., Rascle, A., Zurawski, S., Menon, S. and de Waal Malefyt, R., Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 2004. 4: 679691.
  • 21
    Lew, W., Bowcock, A. M. and Krueger, J. G., Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol. 2004. 25: 295305.
  • 22
    Pilcher, B. K., Dumin, J., Schwartz, M. J., Mast, B. A., Schultz, G. S., Parks, W. C. and Welgus, H. G., Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J. Biol. Chem. 1999. 274: 1037210381.
  • 23
    Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J. et al., Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 2002. 277: 1283812845.
  • 24
    Glaser, R., Harder, J., Lange, H., Bartels, J., Christophers, E. and Schroder, J. M., Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 2005. 6: 5764.
  • 25
    Thorey, I. S., Roth, J., Regenbogen, J., Halle, J. P., Bittner, M., Vogl, T., Kaesler, S. et al., The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J. Biol. Chem. 2001. 276: 3581835825.
  • 26
    Harder, J. and Schroder, J. M., Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 2005. 77: 476486.
  • 27
    Fuchs, E., Epidermal differentiation: the bare essentials. J. Cell Biol. 1990. 111: 28072814.
  • 28
    Pearton, D. J., Dale, B. A. and Presland, R. B., Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J. Invest. Dermatol. 2002. 119: 661669.
  • 29
    Kuechle, M. K., Thulin, C. D., Presland, R. B. and Dale, B. A., Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J. Invest. Dermatol. 1999. 112: 843852.
  • 30
    Porter, R. M., Leitgeb, S., Melton, D. W., Swensson, O., Eady, R. A. and Magin, T. M., Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J. Cell Biol. 1996. 132: 925936.
  • 31
    Mehul, B., Bernard, D., Simonetti, L., Bernard, M. A. and Schmidt, R., Identification and cloning of a new calmodulin-like protein from human epidermis. J. Biol. Chem. 2000. 275: 1284112847.
  • 32
    Fuchs, E. and Weber, K., Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 1994. 63: 345382.
  • 33
    Fuchs, E., Keratins and the skin. Annu. Rev. Cell Dev. Biol. 1995. 11: 123153.
  • 34
    Oomizu, S., Sahuc, F., Asahina, K., Inamatsu, M., Matsuzaki, T., Sasaki, M., Obara, M. and Yoshizato, K., Kdap, a novel gene associated with the stratification of the epithelium. Gene 2000. 256: 1927.
  • 35
    Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T. et al., Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 2004. 122: 12351244.
  • 36
    Franzke, C. W., Baici, A., Bartels, J., Christophers, E. and Wiedow, O., Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J. Biol. Chem. 1996. 271: 2188621890.
  • 37
    Nagase, H. and Woessner, J. F. Jr., Matrix metalloproteinases. J. Biol. Chem. 1999. 274: 2149121494.
  • 38
    Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G. and Parks, W. C., The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 1997. 137: 14451457.
  • 39
    Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K. et al., Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999. 18: 46574668.
  • 40
    Bullard, K. M., Lund, L., Mudgett, J. S., Mellin, T. N., Hunt, T. K., Murphy, B., Ronan, J. et al., Impaired wound contraction in stromelysin-1-deficient mice. Ann. Surg. 1999. 230: 260265.
  • 41
    Li, C. K., Pender, S. L., Pickard, K. M., Chance, V., Holloway, J. A., Huett, A., Goncalves, N. S. et al., Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J. Immunol. 2004. 173: 51715179.
  • 42
    Chitaev, N. A. and Troyanovsky, S. M., Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J. Cell Biol. 1997. 138: 193201.
  • 43
    Goebeler, V., Ruhe, D., Gerke, V. and Rescher, U., Atypical properties displayed by annexin A9, a novel member of the annexin family of Ca(2+) and lipid binding proteins. FEBS Lett. 2003. 546: 359364.
  • 44
    Hayes, M. J., Rescher, U., Gerke, V. and Moss, S. E., Annexin-actin interactions. Traffic 2004. 5: 571576.
  • 45
    Boniface, K., Bernard, F. X., Garcia, M., Gurney, A. L., Lecron, J. C. and Morel, F., IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 2005. 174: 36953702.
  • 46
    Jinquan, T., Vorum, H., Larsen, C. G., Madsen, P., Rasmussen, H. H., Gesser, B., Etzerodt, M. et al., Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 1996. 107: 510.
  • 47
    Blumberg, H., Conklin, D., Xu, W. F., Grossmann, A., Brender, T., Carollo, S., Eagan, M. et al., Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001. 104: 919.
  • 48
    Renauld, J. C., Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 2003. 3: 667676.
  • 49
    Weiss, B., Wolk, K., Grunberg, B. H., Volk, H. D., Sterry, W., Asadullah, K. and Sabat, R., Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun. 2004. 5: 330336.
  • 50
    Liu, A. Y., Destoumieux, D., Wong, A. V., Park, C. H., Valore, E. V., Liu, L. and Ganz, T., Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol. 2002. 118: 275281.
  • 51
    Wolk, K., Docke, W. D., von Baehr, V., Volk, H. D. and Sabat, R., Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000. 96: 218223.
  • 52
    Wolk, K., Kunz, S., Crompton, N. E., Volk, H. D. and Sabat, R., Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J. Biol. Chem. 2003. 278: 1803018036.